NCT03379662: A trial that was reported late by Erchonia Corporation
This trial has reported, although it was 455 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03379662 |
|---|---|
| Title | A Double-blind, Placebo-controlled Randomized Evaluation of the Effect of the Erchonia® HLS Laser Device on Children and Adolescents With Autistic Disorder |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 2, 2017 |
| Completion date | Oct. 28, 2017 |
| Required reporting date | Oct. 28, 2018, midnight |
| Actual reporting date | Jan. 26, 2020 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | 455 |